Scinai Immunotherapeutics (SCNI) Depreciation & Amortization (CF) (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Depreciation & Amortization (CF) of $453000.0 for Q1 2026, up 29.06% on a YoY basis from $351000.0 in Q1 2025, and up 28.33% sequentially from $353000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $453000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 29.06% year-over-year to $453000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 37.26% YoY), and the FY2025 full-year result was $1.4 million, down 13.83% from the prior year.
- Depreciation & Amortization (CF) rose to $453000.0 in Q1 2026, from $353000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $499000.0 in Q4 2024 to a low of $84000.0 in Q4 2023.
- A 5-year average of $258800.0 and a median of $156000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 83.82% in 2022 and jumped 494.05% in 2024, its largest moves.
- Tracing SCNI's Depreciation & Amortization (CF) over 5 years: stood at $184000.0 in 2022, then plunged by 54.35% to $84000.0 in 2023, then jumped by 494.05% to $499000.0 in 2024, then decreased by 29.26% to $353000.0 in 2025, then gained by 28.33% to $453000.0 in 2026.
- Business Quant data shows SCNI's Depreciation & Amortization (CF) at $453000.0 in Q1 2026, $353000.0 in Q2 2025, and $351000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 453,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Mar 31, 2025 | 351,000.00 |
| Mar 31, 2025 | 351,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Sep 30, 2024 | 498,000.00 |
| Sep 30, 2024 | 498,000.00 |
| Jun 30, 2024 | 496,000.00 |
| Jun 30, 2024 | 496,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 145,000.00 |
| Sep 30, 2023 | 145,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Jun 30, 2023 | 147,000.00 |